DNA Vaccine MarketThe global DNA vaccines market is experiencing significant growth because of factors such as the adoption of DNA vaccines in healthcare, low costs of DNA vaccines, and increasing investments in DNA technology. The increase in the prevalence of chronic diseases such as cancer, hepatitis, HIV and others is stimulating the growth of the global DNA vaccine market. Ease of large-scale manufacturing compared to the traditional approach and less storage requirement are the key market drivers of DNA vaccines. The other factors augmenting the growth of the market include increasing clinical trials for DNA vaccines both animal-based and human-based.
However, uncertainty in regulatory policies and less penetration of DNA vaccine technology in the emerging economies are hindering the growth. However, the increasing benefits offered by the DNA based vaccines and increasing awareness will have a considerable impact on the growth of this market.
The global market for DNA vaccines is estimated at 41.83 % of CAGR for the period of 2018-2025.
To request a sample copy or view summary of this report, click the link below:
Based on the type, the DNA vaccines market is divided into recombinant protein and genetic. Amongst the two segments, the recombinant protein segment accounted for the largest share in the market. This large share is attributed to the presence of a high number of recombinant protein vaccines in the market. Based on end-user, the segment market is classified into humans and animals, among which the majority of DNA vaccines available in the market are targeted for humans. Moreover, the strong pipeline of human targeted vaccines is likely to aid the market growth for the forecast period.
North America is the largest market for DNA vaccines. The large share of the market is attributed to the government’s initiatives to immunize citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards animals. The Asia-Pacific region is about to reach the highest growth for the forecast period. This growth is likely to be driven by rising awareness of people regarding the advantages of immunization against HPV and Hepatitis B.
Companies contributing to the growth of the global DNA vaccine market are Astellas Pharma, Bharat Biotech, Dendreon Corporation, Indian Immunologicals Limited, GE Healthcare Life Sciences, GlaxoSmithKline Inc., Green Cross Corporation, Innovation Biomedical Corporation, Pfizer Pharmaceuticals, Sanofi, The Serum Institute of India Pvt. Limited, Zoetis Inc. and so on. US – AgriLabs in November 2017, announced the United States Department of Agriculture (USDA) approval of the first DNA vaccine licensed for chickens.
Contact Us :
Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
About Digits N Markets:
Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.